Affordable Innovation
| Name | Indication | Clinical Trial Phase | Study Title |
|---|---|---|---|
| HLX10+HLX07 |
Head and Neck Squamous Cell Carcinoma
|
phase II | Evaluate the Efficacy and Safety of HLX10 in Combination With HLX07 in Patients With Advanced Head and Neck Tumors |
| HLX14 |
Healthy Male Volunteers
|
Phase I |
First subject has been doesd in the international multi-centre phase 3 clinical trial for HLX14 in China for the treatment of postmenopausal osteoporosis in women with high fracture risks. |
| HLX10 + chemotherapy |
Cervical Cancer
|
phase II |
A Clinical Study to Evaluate Efficacy and Safety of HLX10 Combined With Albumin-Bound Paclitaxel in Patients With Advanced Cervical Cancer Who Have Progressive Disease or Intolerable Toxicity After First-Line Standard Chemotherapy |
| HLX10+Chemotherapy |
Extensive Stage Small Cell Lung Cancer
|
Phase III |
A Randomized, Double-blind, Placebo‑Controlled Phase III Study to Investigate Efficacy and Safety of HLX10 + Chemotherapy (Carboplatin- Etoposide) in Patients With Extensive Stage Small Cell Lung Cancer (ES-SCLC)
|
| HLX10+chemotherapy |
Squamous Non Small Cell Lung Cancer
|
Phase III |
A Randomized, Double-blind, Placebo Controlled Phase III Study to Investigate Efficacy and Safety of First-Line Treatment With HLX10 + Chemotherapy (Carboplatin-Nanoparticle Albumin Bound (Nab) Paclitaxel) in Patients With Stage IIIB/IIIC or IV NSCLC
|
